1. Home
  2. VERU vs NA Comparison

VERU vs NA Comparison

Compare VERU & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • NA
  • Stock Information
  • Founded
  • VERU 1971
  • NA 2019
  • Country
  • VERU United States
  • NA China
  • Employees
  • VERU N/A
  • NA N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • NA Semiconductors
  • Sector
  • VERU Health Care
  • NA Technology
  • Exchange
  • VERU Nasdaq
  • NA Nasdaq
  • Market Cap
  • VERU 94.5M
  • NA 77.6M
  • IPO Year
  • VERU 1990
  • NA 2022
  • Fundamental
  • Price
  • VERU $0.60
  • NA $8.20
  • Analyst Decision
  • VERU Strong Buy
  • NA
  • Analyst Count
  • VERU 2
  • NA 0
  • Target Price
  • VERU $4.00
  • NA N/A
  • AVG Volume (30 Days)
  • VERU 2.8M
  • NA 1.4M
  • Earning Date
  • VERU 08-07-2025
  • NA 03-25-2025
  • Dividend Yield
  • VERU N/A
  • NA N/A
  • EPS Growth
  • VERU N/A
  • NA N/A
  • EPS
  • VERU N/A
  • NA N/A
  • Revenue
  • VERU $16,886,419.00
  • NA $5,561,770.00
  • Revenue This Year
  • VERU N/A
  • NA N/A
  • Revenue Next Year
  • VERU N/A
  • NA N/A
  • P/E Ratio
  • VERU N/A
  • NA N/A
  • Revenue Growth
  • VERU 134.43
  • NA N/A
  • 52 Week Low
  • VERU $0.45
  • NA $2.75
  • 52 Week High
  • VERU $1.42
  • NA $31.48
  • Technical
  • Relative Strength Index (RSI)
  • VERU 51.69
  • NA 47.58
  • Support Level
  • VERU $0.57
  • NA $7.80
  • Resistance Level
  • VERU $0.73
  • NA $31.48
  • Average True Range (ATR)
  • VERU 0.05
  • NA 3.13
  • MACD
  • VERU -0.01
  • NA -0.55
  • Stochastic Oscillator
  • VERU 29.41
  • NA 2.65

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About NA Nano Labs Ltd

Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.

Share on Social Networks: